A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

NCT06979596 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Neoplasm

Interventions

DRUG: Opevesostat
DRUG: Fludrocortisone/ Fludrocortisone acetate
DRUG: Dexamethasone/Dexamethasone acetate
DRUG: Rescue Medications
DRUG: Fulvestrant
DRUG: Exemestane
DRUG: Megestrol acetate/Medroxyprogesterone acetate
DRUG: Tamoxifen
DRUG: Letrozole

Sponsor

Merck Sharp & Dohme LLC